Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
about
Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.More controversy than ever - challenges and promises towards personalized treatment of gastric cancerEffectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancerInnovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.Advanced gastric cancer showing complete remission of metastatic lymph node after chemotherapy.Pathological complete response and long-term survival in a very elderly patient after neoadjuvant chemotherapy for locally advanced, unresectable gastric cancer.Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer?A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors.Robotic surgery for rectal cancer: may it improve also survival?Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trialsComparative effectiveness of hyperthermic intraperitoneal chemotherapy for gastric cancer: A systematic review and network meta-analysis protocolComparative Effectiveness of Neoadjuvant Treatments for Resectable Gastroesophageal Cancer: A Network Meta-Analysis
P2860
Q33672879-628FEC88-37DC-4F77-9915-3E134B335CD3Q36494032-DE3D67F8-69D7-47E2-8A01-8C5A0C6ADDD4Q36529266-2BA7EE71-4513-451D-8C44-778DF8D5F51FQ36671857-08F7C76A-DDB5-467D-8B20-3C186FAA6CDAQ37035264-C8B3F157-5131-4D6A-BE64-73FF816BD5C2Q40607884-446F9019-B487-4919-8A63-8C127BCFACB3Q41952342-C513CC07-8FDA-4269-842A-73093EF31C92Q44130414-09B34D76-64E2-4608-8FD7-F4B545BD0A51Q45119706-F6CD3649-DE27-426C-88AA-72DB66CA1849Q50353991-380ECDF5-B74F-4B90-8570-1EC905DD7884Q51891651-96ABDD21-B34B-49BE-976F-9058EC252E67Q58715779-65326C62-31DA-4A12-83A5-4C9BC7091FCEQ58768727-9D4D5BB7-5066-418A-8DE4-104E2A9E08E4Q58799117-4CE5621F-E88D-420A-B4EC-97606E148929
P2860
Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Selecting a specific pre- or p ...... with operable gastric cancer.
@ast
Selecting a specific pre- or p ...... with operable gastric cancer.
@en
type
label
Selecting a specific pre- or p ...... with operable gastric cancer.
@ast
Selecting a specific pre- or p ...... with operable gastric cancer.
@en
prefLabel
Selecting a specific pre- or p ...... with operable gastric cancer.
@ast
Selecting a specific pre- or p ...... with operable gastric cancer.
@en
P2093
P2860
P356
P1476
Selecting a specific pre- or p ...... with operable gastric cancer.
@en
P2093
Angelos M Kappas
Dimitrios H Roukos
Evangelos Briasoulis
Lefkothea Dova
Michael Fatouros
Pericles Tsekeris
Theodore Liakakos
P2860
P304
P356
10.1586/14737140.6.6.931
P577
2006-06-01T00:00:00Z